Global Continuous Glucose Monitoring (CGM) Market

Executive Summary

1.1 Market Overview

The global continuous glucose monitoring market is moving from periodic glucose testing toward continuous, connected and data-driven monitoring. Growth is supported by rising diabetes prevalence, increasing CGM penetration, improvements in sensor accuracy and wear duration, smartphone and cloud connectivity, integration with insulin pumps and automated insulin delivery, and expansion into Type 2 diabetes, non-insulin users and metabolic-health applications.

1.2 Key Market Findings

• Global CGM market size was approximately USD 12.6 billion in 2025.
• Market growth is expected at about 16.5% CAGR during 2026–2034.
• Rising diabetes prevalence and demand for continuous glucose data remain primary growth drivers.
• Miniaturization, accuracy, longer wear, smartphone integration and AI are key technology themes.
• Type 2 diabetes, non-insulin users and OTC CGM expand the addressable market.
• Recurring sensor consumption, subscriptions and digital services support attractive commercial models.

1.3 Market Size & Growth Outlook

The global continuous glucose monitoring market was valued at approximately USD 12.6 billion in 2025 and is projected to expand at a CAGR of about 16.5% during 2026–2034. The implied market size at the end of the forecast period is approximately USD 50.5 billion. Growth is expected to broaden as CGM moves beyond traditional insulin-intensive applications into wider Type 2, non-insulin, OTC and metabolic-health use cases.

1.4 Key Strategic Takeaways

Technology performance, patient expansion, OTC access, recurring revenue models and integration with connected healthcare ecosystems are expected to shape competitive positioning.

Market Definition & Scope

2.1 Market Definition

Continuous glucose monitoring (CGM) refers to systems that continuously or near-continuously measure glucose levels through a wearable sensor and communicate glucose data to a receiver, reader or connected digital platform.

2.2 CGM vs. BGM vs. Flash Glucose Monitoring

2.3 CGM Device Ecosystem

The ecosystem includes sensor manufacturers, transmitters/readers, mobile applications, cloud platforms, insulin-delivery systems, healthcare providers, payers, pharmacies and digital-health partners.

2.4 Components of a CGM System

Sensors, transmitters, receivers/readers and software or digital platforms form the core system architecture.

2.5 Market Scope & Research Methodology

The study evaluates market development across product, component, patient, usage, distribution and geographic dimensions, supported by primary and secondary research.

2.6 Data Sources

2.6.1 Primary Data Sources

Primary research includes interviews and market inputs from industry participants, healthcare stakeholders and relevant experts.

2.6.2 Secondary Data Sources

Secondary research includes company disclosures, regulatory sources, industry publications, healthcare datasets and other relevant market information.

CGM Market Overview

3.1 Evolution of CGM Technology

CGM technology has evolved from larger, more complex systems toward smaller, longer-wear and increasingly connected devices. Improvements in sensor performance, usability and digital connectivity have supported broader adoption.

3.2 Market Ecosystem and Landscape

The market spans device manufacturers, component suppliers, software platforms, healthcare providers, payers, pharmacies, digital-health companies and insulin-delivery partners.

3.3 Market Dynamics

3.3.1 Market Drivers

Rising diabetes prevalence, increasing awareness, broader adoption, technology improvements, connected care and expanding use cases support market growth.

3.3.2 Market Restraints and Challenges

Affordability, reimbursement variability, device access, user adherence, data integration and regulatory requirements can constrain adoption.

3.3.3 Market Opportunities

OTC CGM, Type 2 diabetes, non-insulin users, emerging markets, metabolic-health applications and AI-enabled analytics create incremental opportunities.

3.4 Adoption & Demand Analysis

3.4.1 Diabetes Prevalence & Incidence

Growing diabetes prevalence expands the underlying addressable population for glucose-monitoring technologies.

3.4.2 Insulin-Treated Population

Insulin-treated populations remain an important CGM user base, particularly where continuous data supports intensive diabetes management.

3.4.3 CGM Adoption across Diabetes Population, By Region

Adoption varies materially by reimbursement, affordability, awareness, healthcare infrastructure and product availability.

3.4.4 Adoption Trends: Type 1 vs. Type 2 Diabetes, By Region

CGM is expanding beyond Type 1 diabetes as access, evidence and product positioning broaden.

3.4.5 CGM Adoption in Insulin Users vs. Non-Insulin Users, By Region

Growth among non-insulin users represents an important expansion of the addressable market.

3.4.6 Total Prescription vs. OTC CGM Patients, By Region

Prescription and OTC pathways are creating differentiated commercial routes and customer segments.

3.4.7 Metabolic Health/Wellness Applications

Consumer-facing applications are extending CGM into nutrition, exercise and metabolic-health use cases.

3.5 Porter’s Five Forces Analysis

Competitive intensity, supplier dynamics, customer power, substitution and barriers to entry are assessed across the CGM value chain.

3.6 PESTLE Analysis

Political, economic, social, technological, legal and environmental factors are evaluated for their impact on market development.

CGM Technology Landscape

Coverage includes sensor technology; enzymatic vs. emerging sensors; calibration; wear duration; implantable vs. transcutaneous systems; accuracy and MARD; warm-up time; connectivity; smartphone integration; cloud data management; AI and predictive analytics; closed-loop/AID integration; and emerging CGM technologies.

Pricing & Commercial Landscape

Coverage includes device pricing, sensor pricing, monthly CGM cost, subscription models, insurance-reimbursed pricing, cash-pay/self-pay markets and OTC pricing, with regional comparisons.

Reimbursement & Payer Landscape

Coverage includes global reimbursement, public vs. private insurance, Medicare/Medicaid, European reimbursement and Asia-Pacific reimbursement dynamics.

Regulatory Landscape

Coverage includes global frameworks, U.S. FDA, Europe, Asia-Pacific, OTC CGM regulation, clinical evidence requirements, data privacy and cybersecurity, and recent regulatory approvals.

Innovation & Pipeline Analysis

Coverage includes emerging technologies, next-generation sensors, longer-duration sensors, non-invasive and implantable CGM, needle-free technologies, AI-enabled CGM, miniaturization, future product pipelines and startup innovation.

Global CGM Market Size & Forecast

Coverage includes global market size and forecast for 2022–2034, revenue by product type, patient type, end user, distribution channel, region/key countries and market opportunity analysis.

Competitive Landscape

Coverage includes major market participants, market share analysis, company positioning, revenue and growth comparison, M&A, product launches, partnerships and market expansion.

Product & Competitive Benchmarking

Coverage includes major CGM products, feature comparison, battery life, accuracy, connectivity and app ecosystems, pricing by region and pricing models.

Market Segmentation Analysis

Segmentation covers product type, component, patient type, usage and distribution channel.

Regional Market Analysis

Coverage includes North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, with country-level analysis, market size and forecast, adoption trends, regional players and growth opportunities.

Company Profiles

Coverage includes Dexcom, Abbott Laboratories, Medtronic, Senseonics, Roche, Ascensia Diabetes Care and emerging Chinese/regional players, with company overview, financial performance, CGM portfolio, recent developments, strategic outlook and SWOT analysis.

CGM + Digital Health Ecosystem

Coverage includes CGM data platforms, mobile health applications, AI-based glucose analytics, telehealth, electronic health records, remote patient monitoring, digital therapeutics, CGM data monetization, and API/platform ecosystems.